Syngene International Ltd share price logo

Syngene International Ltd Share Price

NSE: SYNGENE

BSE: 539268

Small Cap

Healthcare Sector

₹636.45

-3.95

(-0.62%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Syngene International Ltd Stock Performance

as on October 17, 2025 at 10:27 am IST

  • Day's Low

    Day's High

    ₹635.4
    ₹644.65
    downward going graph

    0.16%

    Downside

    1.29%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹599.55
    ₹960.6
    downward going graph

    5.80%

    Downside

    50.93%

    Upside

    downward going graph

Syngene International Ltd share price movements today

Previous Close
₹640.40
Open
₹636.45
Volume
49.47K
Upper Circuit
₹704.40
Lower Circuit
₹576.40
Day's Low - High
₹635.4 - ₹644.65
52 Week Low - High
₹599.55 - ₹960.6

Syngene International Ltd Historical Returns

1 Month Return
-1.66 %
3 Month Return
-4.47 %
1 Year Return
-27.11 %
3 Year Return
+ 18.99 %
5 Year Return
+ 15.4 %

Syngene International Ltd Fundamentals

as on October 17, 2025 at 10:27 am IST

Market Cap

₹25,804.24 Cr

Return on Equity (ROE)

10.6

PE Ratio (TTM)

50.7

Return on capital employed (ROCE)

13.04

Industry PE ratio

52.49

Beta (LTM)

0.87

P/B Ratio

6.3

Dividend Yield

0.17

PEG Ratio

140.85

Quarterly Earnings Growth YOY

14.53

EPS (TTM)

12.33

Sector

Healthcare

Book Value

117.44

Technical Analysis

Bearish

View Technical Analysis

Syngene International Ltd Stock Valuation

as on October 17, 2025 at 10:27 am IST

Syngene International Ltd in the last 5 years

  • Overview

  • Trends

Lowest (23.09x)

March 31, 2020

Today (50.70x)

October 16, 2025

Industry (52.49x)

October 16, 2025

Highest (78.92x)

December 2, 2024

LowHigh

Today’s Price to Earnings Ratio: 50.70x

Syngene International Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Syngene International Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Syngene International Ltd image
Syngene International Ltd
BUY25,804.243.08%0.584963,642
Sanofi India Ltd image
Sanofi India Ltd
BUY10,799.23-9.17%0.524132,013
Aurobindo Pharma Ltd image
Aurobindo Pharma Ltd
BUY64,822.397.64%0.603,48331,723
Zydus Lifesciences Ltd image
Zydus Lifesciences Ltd
HOLD99,073.8026.59%0.614,61423,241
Abbott India Ltd image
Abbott India Ltd
BUY63,399.3817.75%0.001,4146,445
See all

Analyst Recommendation on Syngene International Ltd Stock

Based on 8 analysts

BUY

62.50%

Buy

12.50%

Hold

25.00%

Sell

Based on 8 analysts, 62.5% of analysts recommend a 'BUY' rating for Syngene International Ltd. Average target price of ₹715.62

Source: S&P Global Market Intelligence

Syngene International Ltd Share Price Target

Get share price movements and forecasts by analysts on Syngene International Ltd.

What analysts predicted

11.75%UPSIDE

Target Price

₹715.62

Current Price

₹636.45

Analyzed by

8 Analysts

High

₹840

Target

₹715.62

Low

₹570

Syngene International Ltd target price ₹715.62, a slight upside of 11.75% compared to current price of ₹636.45. According to 8 analysts rating.

Source: S&P Global Market Intelligence

Syngene International Ltd Stock’s Investor Sentiment and Interest

Search interest for Syngene International Ltd Stock has increased by 30% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:30% versus previous 30 day period

Syngene International Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
785.9
994.4
808.1
910.1
853.5
916.9
789.7
891
943.7
1,018
874.5
Other Income
17.2
22.8
23.6
21.6
29.3
16.1
50.1
16.5
18.3
18.9
17.7
Total Income
803.1
1,017.2
831.7
931.7
882.8
933
839.8
907.5
962
1,036.9
892.2
Expenses
554.9
680.3
596.2
663.4
625.7
600
619.9
646.2
660.1
674.4
668.1
Operating Profit
231
314.1
211.9
246.7
227.8
316.9
169.8
244.8
283.6
343.6
206.4
Operating Profit Margin %
29.39%
31.59%
26.22%
27.11%
26.69%
34.56%
21.5%
27.47%
30.05%
33.75%
23.6%
Profit Before Interest, Tax and Depreciation
248.2
336.9
235.5
268.3
257.1
333
219.9
261.3
301.9
362.5
224.1
Interest
13.7
10.4
10.5
13
10.8
12.9
11.7
13.1
12.4
15.9
11.6
Depreciation
94.6
95.6
102.1
104.6
108.1
111.1
106.9
110.9
108.7
106.1
111.2
Profit Before Tax
139.9
230.9
122.9
150.7
138.2
209
101.3
137.3
180.8
240.5
101.3
Tax Paid
30.2
52.2
29.5
34.2
26.7
20.4
25.6
31.2
49.7
57.2
14.6
Profit After Tax
109.7
178.7
93.4
116.5
111.5
188.6
75.7
106.1
131.1
183.3
86.7
Total Net profit including share of profit / Loss from associate company
109.7
178.7
93.4
116.5
111.5
188.6
75.7
106.1
131.1
183.3
86.7
EPS
2.74
4.36
2.33
2.9
2.78
4.7
1.89
2.64
3.27
4.56
2.16
Actual EPS
2.74
4.36
2.33
2.9
2.78
4.7
1.89
2.64
3.27
4.56
2.16
Adjusted EPS
2.74
4.36
2.33
2.9
2.78
4.7
1.89
2.64
3.27
4.56
2.16
Diluted EPS
2.71
4.43
2.32
2.9
2.77
4.69
1.88
2.64
3.26
4.56
2.16

Syngene International Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
1,423.1
1,825.6
2,011.9
2,184.3
2,604.2
3,192.9
3,488.6
3,642.4
Other Income
61.8
75.1
152.9
99.6
52.8
70.9
90.6
103.8
Total Income
1,484.9
1,900.7
2,164.8
2,283.9
2,657
3,263.8
3,579.2
3,746.2
Expenses
958.3
1,288.8
1,394
1,512.5
1,838.8
2,258.5
2,485.3
2,600.6
Operating Profit
464.8
536.8
617.9
671.8
765.4
934.4
1,003.3
1,041.8
Operating Profit Margin %
32.66%
29.4%
30.71%
30.76%
29.39%
29.26%
28.76%
28.6%
Profit Before Interest, Tax and Depreciation
526.6
611.9
770.8
771.4
818.2
1,005.3
1,093.9
1,145.6
Interest
22.7
32.3
34.6
27.7
24.1
45.2
47.2
53.1
Depreciation
131.4
164.2
219.3
274.5
309.7
366.5
425.9
432.6
Profit Before Tax
372.5
415.4
516.9
469.2
484.4
593.6
620.8
659.9
Tax Paid
67.1
83.8
104.8
64.3
88.6
129.2
110.8
163.7
Profit After Tax
305.4
331.6
412.1
404.9
395.8
464.4
510
496.2
Total Net profit including share of profit / Loss from associate company
305.4
331.6
412.1
404.9
395.8
464.4
510
496.2
EPS
15.47
8.39
10.38
10.18
9.94
11.59
12.71
12.35
Actual EPS
15.47
8.39
10.38
10.18
9.94
11.59
12.71
12.35
Adjusted EPS
7.74
4.2
10.38
10.18
9.94
11.59
12.71
12.35
Diluted EPS
15.43
8.36
10.35
10.11
9.82
11.51
12.69
12.34

Syngene International Ltd Cash Flow

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
446.2
630.4
677.1
701.2
580.6
823.5
1,042.1
1,167.6
Cash Flow from Investing Activities
-349.3
-645.5
-423.8
-628.9
-610.8
-653.3
-494.5
-744.4
Cash Flow from Financing Activities
-78.7
-72.4
-225.5
58
-31.3
-342.5
-551.4
-141.8
Net Cash Flow
18.2
-87.5
27.8
130.3
-61.5
-172.3
-3.8
281.4

Syngene International Ltd Stock Shareholding Pattern

Numbers in percentages

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Promoters
64.86%
54.88%
54.8%
54.79%
54.79%
54.79%
54.72%
54.72%
52.74%
52.74%
52.68%
DII
7.04%
10.73%
11.2%
9.94%
13.08%
15.8%
16.8%
17.48%
19.53%
21.5%
24.05%
FII
0.02%
0.02%
0%
0%
0%
20.92%
20.63%
20.72%
20.64%
19.47%
16.5%
Public
10.77%
10.63%
10.21%
9.46%
9.05%
8.17%
7.42%
6.74%
6.8%
6%
6.45%
Total Outstanding Shares
40,14,34,500
40,14,34,500
40,20,15,000
40,20,15,000
40,20,15,000
40,20,15,000
40,25,36,981
40,25,36,981
40,25,36,981
40,25,36,981
40,29,39,420
Total Shareholders
1,27,964
1,24,014
1,25,455
1,25,992
1,21,880
1,15,850
1,20,018
1,07,338
1,28,806
1,25,090
1,42,310

Mutual Funds that own Syngene International Ltd Stock

Check out the Mutual Funds with significant holdings in Syngene International Ltd.

Syngene International Ltd Corporate Actions

View detailed summary of the earnings and dividend history of Syngene International Ltd.

  • Syngene International Ltd Earnings Results

    Syngene International Ltd’s net profit jumped 14.53% since last year same period to ₹86.70Cr in the Q1 2025-2026. On a quarterly growth basis, Syngene International Ltd has generated -52.7% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Syngene International Ltd Dividends April,2025

    In the quarter ending March 2025, Syngene International Ltd has declared dividend of ₹1.25 per share on 23 Apr 2025 - translating a dividend yield of 0.39%.

    Read More about Dividends

Indices Featuring Syngene International Ltd Stock

Check stock indices that include Syngene International Ltd.

S&P BSE 150 MidCap

₹16,282.02

-0.17 (▲-27.4%)

S&P BSE 250 LargeMidCap

₹11,035.69

0.2 (▲21.52%)

Nifty Healthcare

₹14,797.35

0.29 (▲42.15%)

Nifty MidSmallcap 400

₹20,162.55

-0.05 (▲-10.15%)

BSE 500

₹37,051.81

0.18 (▲67.28%)

BSE Healthcare

₹44,739.30

0.13 (▲59.19%)

Nifty Midcap 150

₹21,877.25

-0.11 (▲-23.65%)

S&P BSE SmallCap Select

₹8,169.37

-0.04 (▲-3.01%)

Nifty LargeMidcap 250

₹16,581.80

0.09 (▲14.2%)

S&P BSE 400 MidSmallCap

₹12,179.13

-0.09 (▲-10.52%)

BSE Small-Cap

₹53,254.01

-0.09 (▲-49.71%)

Nifty 500

₹23,607.00

0.18 (▲43.2%)

Insights on Syngene International Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 6.00% to 6.45% in Jun 2025 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 17.86% to 20.70% in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Vimta Labs Ltd has given 150.2% return, outperforming this stock by 179.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Vimta Labs Ltd has given 279.8% return, outperforming this stock by 263.1%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 1.03K Cr → 892.2 Cr (in ₹), with an average decrease of 14.0% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, SYNGENE stock has moved down by -13.9%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 19.47% to 16.50% in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 183.3 Cr → 86.7 Cr (in ₹), with an average decrease of 52.7% per quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 52.74% to 52.68% in Jun 2025 quarter

Syngene International Ltd Stock Futures & Options Contracts

View the latest movement in Syngene International Ltd Futures & Options, including strike prices, expiry dates, and percentage changes.

Syngene International Ltd Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
SYNGENE 28 Oct ₹620 Call
October 28, 2025
₹620
₹25.45
6.6
35.01%
SYNGENE 28 Oct ₹640 Call
October 28, 2025
₹640
₹10.7
-2.1
-16.41%
SYNGENE 28 Oct ₹610 Call
October 28, 2025
₹610
₹34.4
8.5
32.82%
SYNGENE 28 Oct ₹700 Call
October 28, 2025
₹700
₹0.6
-0.25
-29.41%

Syngene International Ltd Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
SYNGENE 28 Oct Fut
October 28, 2025
-
₹639.1
-2.76
-0.43%
SYNGENE 25 Nov Fut
November 25, 2025
-
₹641.6
-3.94
-0.61%
SYNGENE 30 Dec Fut
December 30, 2025
-
₹644.5
-5.2
-0.8%

About Syngene International Ltd

Syngene International Limited is a India-based research, development, and manufacturing services organization driven by a team of 5200 scientists. It focuses primarily on the pharmaceutical and biotechnology sectors, and also provides services for nutrition, animal health, consumer goods, and other chemical sectors. The company’s health-related services extends across all major therapy areas and modalities. The operations are spread across 2 million sq. ft. with facilities at Bangalore, Hyderabad, and Mangalore. Syngene International Limited was incorporated in 1993 and consistently has entered into partnerships for research and development. This helped Syngene International cross an annual turnover of Rs 1000 crore in the year 2016. Over the years leading up to 2021, Syngene International expanded its research collaboration with companies such as Abbott, Bristol Myers Squibb, Herbalife, and Glaxo Smith Kline. It also commissioned new facilities and added bioreactors and microbial manufacturing capacity to strengthen biologics manufacturing. With investments in R&D and strengthening scientific capabilities, Syngene International continues to provide integrated drug discovery services.

Revenue: ₹874.50Cr as on June 2025 (Q1 FY26)
Net Profit: ₹86.70Cr as on June 2025 (Q1 FY26)
Listing date: 11 Aug, 2015
Chairperson Name: Kiran Mazumdar Shaw
OrganisationSyngene International Ltd
IndustryHealthcare
CEOKiran Mazumdar Shaw
E-voting on sharesClick here to vote

FAQs

What is Syngene International Ltd share price today?

Syngene International Ltd share price today stands at ₹636.45 as on . Syngene International Ltd share today touched a day high of ₹644.65 and a low of ₹635.4.

What is the 52 week high and 52 week low range for Syngene International Ltd share?

Syngene International Ltd touched a 52 week high of ₹960.6 and a 52 week low of ₹599.55. Syngene International Ltd share price today i.e. is trending at ₹636.45, which is -33.74% down from its 52 week high and 6.15% up from its 52 week low.

What is Syngene International Ltd's market capitalisation today?

Syngene International Ltd market capitalisation is ₹25,804.24 Cr as on .

How to buy Syngene International Ltd shares?

To buy Syngene International Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SYNGENE or Syngene International Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Syngene International Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Syngene International Ltd trading volume today?

Syngene International Ltd trading volume is 49.47K as on . This means that 49.47K shares of Syngene International Ltd were bought and sold on the stock market during today's trading session.